It has been reported, however, that changes in HER2 expression actually seem to be extremely rare although a few cases have been reported, and the HER2 expression is stable between metastases and corresponding primary tumours (Carlsson et al., 2004). This evidence concerns the gene ERBB2 and neoplasm.